Status | Study |
Enrolling by invitation |
Study Name: An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients Condition: Neuromyelitis Optica Neuromyelitis Optica Spectrum Disorder Date: 2013-11-18 Interventions: Biological: eculizumab Other Name: Soliris |
Completed |
Study Name: Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations Condition: Neuromyelitis Optica Neuromyelitis Optica Spectrum Disorder Date: 2013-01-21 Interventions: Drug: Bevacizumab Other Name: Avastin |
Recruiting |
Study Name: A Longitudinal Study of Neuromyelitis Optica and Transverse Myelitis Condition: Neuromyelitis Optica Neuromyelitis Optica Spectrum Disorder Date: 2012-06-15 |
Active, not recruiting |
Study Name: Maintenance Plasma Exchange for Neuromyelitis Optica Condition: Neuromyelitis Optica Neuromyelitis Optica Spectrum Disorder Date: 2011-12-23 Interventions: Procedure: Plasma exchange (PLEX) Regular maintenance PLEX courses, typically 3 procedures monthly |
Active, not recruiting |
Study Name: CNS Growth Factors Release and Changes in the Inflammatory Environment in Response to Electrical Stimulation in Subjects With Inflammatory Myelopathies Condition: Inflammatory Myelopathies Date: 2011-09-22 Interventions: Device: FES Cycling You will b |
Recruiting |
Study Name: Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct Condition: Multiple Sclerosis Neuromyelitis Optica Date: 2009-12-02 |
Enrolling by invitation |
Study Name: Serum Auto-Antibodies in Neurological Diseases Condition: Multiple Sclerosis Myasthenia Gravis Transverse Date: 2008-06-23 Interventions: Other: Blood Draw A 5cc sample |
Completed |
Study Name: Safety and Tolerability of Rituximab in Neuromyelitis Optica Condition: Neuromyelitis Optica Date: 2007-07-12 Interventions: Drug: Rituximab Rituximab is a highly purified, 1328-amino acid antibody with an approximate molecular m |
Active, not recruiting |
Study Name: Biobank For MS And Other Demyelinating Diseases Condition: Multiple Sclerosis Transverse Myelitis Date: 2007-03-08 |
Completed |
Study Name: A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) Condition: Neuromyelitis Optica Myelitis, Transverse Date: 2006-03-15 Interventions: Drug: Mitoxantrone |